Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.

Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- ChecktodayChange DetectedThe page updates from Revision: v3.0.1 to v3.0.2, signaling a minor update; the 'Back to Top' link was removed, a small navigational change with no evident impact on core content.SummaryDifference0.2%
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional publications related to drug safety and specific medical conditions. Notably, the drug 'plozasiran' is highlighted, indicating a focus on its management of certain diseases.SummaryDifference18%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.